Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States | CDC RFA IP13 130605CONT17

Opportunity Information: Apply for CDC RFA IP13 130605CONT17

The funding opportunity titled "Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States" is a continuation grant mechanism issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC). It is designed to support ongoing work that strengthens national-level capacity for detecting, monitoring, and responding to avian influenza and potential pandemic influenza threats in countries outside the United States. In practical terms, the opportunity is focused on sustaining and advancing established influenza surveillance and response systems managed by national health authorities, rather than launching entirely new programs.

This announcement is identified by Funding Opportunity Number CDC RFA IP13 130605CONT17 and is offered as a cooperative agreement. A cooperative agreement generally signals that CDC expects to have substantial involvement in the funded activities beyond simply providing funds, such as technical guidance, collaboration on implementation approaches, assistance with performance monitoring, and alignment with international standards and public health priorities. The activity category is Health, and it is tied to CFDA (Catalog of Federal Domestic Assistance) number 93.318, which corresponds to CDC programs that support public health preparedness and related international health work.

The eligible applicant category is listed as "Others," with additional eligibility details referenced as being located in an accompanying eligibility clarification field. While the text provided does not spell out those details, the title makes clear the intended implementers: national health authorities outside the United States, or entities operating under or in close partnership with them. The opportunity anticipates making around 10 awards, indicating that CDC planned to continue support to a limited number of national programs or country partners already engaged in influenza surveillance and response efforts.

Key timing details include a creation date of March 2, 2017, with an original closing date of April 30, 2017. Because it is a continuation opportunity, this timeline likely relates to renewing or extending existing cooperative agreements, ensuring uninterrupted surveillance operations, laboratory testing capability, data reporting, outbreak investigation readiness, and preparedness planning for influenza threats that can emerge and spread internationally.

The award ceiling is listed as 0, which typically means the public listing does not specify a maximum award amount in the summary record. This can happen when funding levels vary by recipient, depend on negotiated workplans, are determined by available appropriations, or are documented in the full funding announcement rather than the high-level synopsis. The absence of a stated ceiling should not be interpreted as unlimited funding; it usually reflects that a fixed cap was not published in this particular summary entry.

Overall, the opportunity is best understood as CDC support for sustained international influenza vigilance: maintaining strong surveillance networks, improving the timeliness and quality of detection and reporting, and reinforcing rapid response capabilities for avian influenza events and potential pandemic influenza emergence. The core public health rationale is that early detection and containment abroad helps reduce global risk, supports international health security, and improves readiness for influenza threats that can cross borders quickly.

• The Department of Health and Human Services, Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
• This funding opportunity was created on Mar 02, 2017.
• Applicants must submit their applications by Apr 30, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA IP13 130605CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: